{"address1": "108 Patriot Drive", "address2": "Suite A", "city": "Middletown", "state": "DE", "zip": "19709", "country": "United States", "phone": "302 274 8744", "website": "https://www.zymeworks.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a human epidermal growth factor receptor 2 (HER2) that is in Phase 1, Phase 2, and Phase 3 clinical trials, including certain ongoing pivotal clinical trials; and zanidatamab zovodotin, a HER2 -targeted antibody-drug conjugate that is in Phase 2 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. It also develops a pipeline of preclinical product candidates and discovery-stage programs in oncology, including immuno-oncology agents and other therapeutic areas. The Zymeworks Inc. has strategic partnerships and collaborations with BeiGene, Ltd.; Celgene Corporation; Celgene Alpine Investment Co. LLC; GlaxoSmithKline Intellectual Property Development Limited; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; LEO Pharma A/S; Iconic Therapeutics, Inc.; Merck Sharp & Dohme Research GmbH; and Atreca, Inc. Zymeworks Inc. was incorporated in 2003 and is based in Middletown, Delaware.", "fullTimeEmployees": 280, "companyOfficers": [{"maxAge": 1, "name": "Mr. Kenneth H. Galbraith C.A.", "age": 61, "title": "Chairman of the Board, CEO & President", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 1155944, "exercisedValue": 0, "unexercisedValue": 713800}, {"maxAge": 1, "name": "Ms. Leone D. Patterson CPA, M.B.A.", "age": 62, "title": "Executive VP and Chief Business & Financial Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 317579, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Paul A. Moore Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 757501, "exercisedValue": 0, "unexercisedValue": 1359800}, {"maxAge": 1, "name": "Mr. Mark  Hollywood", "age": 54, "title": "Executive VP and Head of Technical & Manufacturing Operations", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shrinal  Inamdar", "title": "Director of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Dex J.D., Ph.D.", "title": "Senior VP, Corporate Secretary & General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Diana  Papove", "title": "Senior Manager of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lindsey  Foulkes B.Sc., Ph.D.", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Laura  O'Connor", "title": "Vice President of Human Resources & DEI", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey  Smith M.D.", "age": 64, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 7, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.91, "open": 11.81, "dayLow": 11.489, "dayHigh": 12.05, "regularMarketPreviousClose": 11.91, "regularMarketOpen": 11.81, "regularMarketDayLow": 11.489, "regularMarketDayHigh": 12.05, "payoutRatio": 0.0, "beta": 1.132, "forwardPE": -6.916667, "volume": 680431, "regularMarketVolume": 680431, "averageVolume": 531681, "averageVolume10days": 581380, "averageDailyVolume10Day": 581380, "bid": 11.57, "ask": 11.66, "bidSize": 1, "askSize": 1, "marketCap": 808483520, "fiftyTwoWeekLow": 7.97, "fiftyTwoWeekHigh": 17.7, "priceToSalesTrailing12Months": 10.595559, "fiftyDayAverage": 13.489, "twoHundredDayAverage": 12.579, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 601241408, "profitMargins": -1.60798, "floatShares": 39116819, "sharesOutstanding": 69576896, "sharesShort": 5415327, "sharesShortPriorMonth": 3837127, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.077800006, "heldPercentInsiders": 0.0018600001, "heldPercentInstitutions": 1.01276, "shortRatio": 8.16, "shortPercentOfFloat": 0.101, "impliedSharesOutstanding": 69576896, "bookValue": 4.912, "priceToBook": 2.3656352, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -122695000, "trailingEps": -1.62, "forwardEps": -1.68, "enterpriseToRevenue": 7.88, "enterpriseToEbitda": -5.32, "52WeekChange": 0.20664585, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 11.62, "targetHighPrice": 30.0, "targetLowPrice": 12.0, "targetMeanPrice": 21.35, "targetMedianPrice": 19.25, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 225776000, "totalCashPerShare": 3.245, "ebitda": -113017000, "totalDebt": 18534000, "quickRatio": 3.189, "currentRatio": 3.403, "totalRevenue": 76304000, "debtToEquity": 5.471, "revenuePerShare": 1.006, "returnOnAssets": -0.14571999, "returnOnEquity": -0.30537, "grossProfits": -60195000, "freeCashflow": -52158124, "operatingCashflow": -110044000, "revenueGrowth": 0.833, "grossMargins": -0.78888, "ebitdaMargins": -1.48114, "operatingMargins": -0.71596, "financialCurrency": "USD", "symbol": "ZYME", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Zymeworks Inc.", "corporateActions": [], "preMarketTime": 1743595201, "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_43279463", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -1.8690004, "fiftyDayAverageChangePercent": -0.13855737, "twoHundredDayAverageChange": -0.9590006, "twoHundredDayAverageChangePercent": -0.076238215, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-12-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1493386200000, "preMarketChange": 0.8505001, "preMarketChangePercent": 7.3192782, "preMarketPrice": 12.4705, "regularMarketChange": -0.28999996, "regularMarketDayRange": "11.489 - 12.05", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 531681, "fiftyTwoWeekLowChange": 3.65, "fiftyTwoWeekLowChangePercent": 0.4579674, "fiftyTwoWeekRange": "7.97 - 17.7", "fiftyTwoWeekHighChange": -6.080001, "fiftyTwoWeekHighChangePercent": -0.34350285, "fiftyTwoWeekChangePercent": 20.664585, "earningsTimestamp": 1741208700, "earningsTimestampStart": 1746043200, "earningsTimestampEnd": 1746475200, "earningsCallTimestampStart": 1741210200, "earningsCallTimestampEnd": 1741210200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.62, "epsForward": -1.68, "epsCurrentYear": -1.70096, "priceEpsCurrentYear": -6.831436, "longName": "Zymeworks Inc.", "regularMarketChangePercent": -2.4349284, "regularMarketPrice": 11.62, "displayName": "Zymeworks", "trailingPegRatio": null}